3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Breast Neoplasms
3
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Uveal Melanoma
1
Smoking Cessation
1
Pancreatic Neoplasms
1
Overweight
1
Multiple Myeloma
1
Motor Activity
1
Melanoma
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Inflammation
1
Healthy Diet
1
Fatigue
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Interventions
pembrolizumab
5
Nivolumab
3
Ipilimumab
3
lenvatinib
2
trametinib
1
tislelizumab
1
tebentafusp
1
spartalizumab
1
ruxolitinib
1
omipalisib
1
binimetinib
1
belinostat
1
avelumab
1
Vorinostat
1
Valproic Acid
1
Tape Recording
1
Sunitinib
1
Solutions
1
Practice Guidelines as Topic
1
Pemetrexed
1
Methods
1
Melphalan
1
Iodized Oil
1
Health Promotion
1
GSK2141795
1
Ethiodized Oil
1
Epilim
1
Educational Status
1
Diet Therapy
1
Data Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Uveal Melanoma
×
Diet Therapy
×
Clear all
NCT04645680
2026-01-30
DIET
M.D. Anderson Cancer Center
Phase 2
Active not recruiting
50 enrolled